Google Seeks U.S. Approval to Release 32 Million Sterilised Mosquitoes in Disease Control Experiment

Google is seeking regulatory approval in the United States to release up to 32 million sterilised mosquitoes into the environment as part of an ambitious experimental programme aimed at reducing mosquito-borne diseases through biological control methods.

The proposal, which is currently under review by the U.S. Environmental Protection Agency (EPA), would authorise the release of up to 16 million mosquitoes annually over a two-year period in selected areas of California and Florida, subject to public consultation and environmental assessments.

The initiative forms part of Google’s “Debug” project, a biotechnology and public health programme that combines artificial intelligence, data science and biological engineering to tackle populations of disease-carrying mosquitoes. The approach is based on a “sterile male release” strategy, in which only non-biting male mosquitoes are released into the wild.

These male mosquitoes are infected with a naturally occurring bacterium known as Wolbachia, which disrupts mosquito reproduction. When sterilised males mate with wild females, the resulting eggs do not hatch, gradually reducing mosquito populations over time without the use of chemical insecticides.

Google’s project specifically targets Aedes aegypti, a mosquito species responsible for transmitting diseases such as dengue fever, Zika virus, yellow fever and chikungunya. Public health experts have long identified the species as one of the most dangerous disease vectors globally.

The company says the programme relies on automated breeding systems, sensor technology and artificial intelligence to mass-produce and sort mosquitoes, ensuring that only males are released into the environment. Advanced computer vision tools are reportedly used to distinguish between male and female mosquitoes with high precision before deployment.

If approved, the programme would mark one of the largest sterile insect release experiments ever attempted in the United States and a significant expansion of technology-driven approaches to disease prevention. Google argues that traditional mosquito control methods, including chemical insecticides, are becoming less effective due to growing resistance and may pose long-term environmental risks.

The concept behind the initiative is not entirely new. Similar Wolbachia-based mosquito release programmes have been tested in countries such as Singapore, where health authorities reported substantial reductions in mosquito populations and significant declines in dengue transmission following sustained deployments.

According to data from earlier trials, such interventions have achieved reductions in mosquito populations and disease incidence ranging from 70 percent to as high as 90 percent in some monitored areas, strengthening global interest in biological vector control methods.

The Debug project also draws on expertise from other Alphabet-affiliated life sciences and health technology initiatives, including previous research conducted by Verily, which has explored data-driven approaches to disease prevention and public health monitoring.

However, the proposal is expected to face scrutiny from regulators, environmental groups and public stakeholders, particularly around ecological safety, long-term biodiversity impacts and the ethics of releasing genetically or biologically modified organisms into open ecosystems.

The EPA’s review process will include an evaluation of potential environmental risks, containment safeguards and community impact assessments before any approval is granted. A public comment period is currently ongoing and is expected to influence the final decision.

If approved, Google’s initiative could signal a major shift in how large technology companies engage with global health challenges, positioning AI-driven biotechnology as a growing frontier in disease prevention and environmental intervention.